Michael Karras, MD

Office Address

Department of Neurology 
University of Kentucky Medical Center
KY Clinic, J-401
Lexington, KY 40536-0284

Personal Statement

Seeing patients progress and witnessing their strength and resiliency from childhood to adulthood attracted Mike to the field of child neurology. Now pursuing his residency, Mike brings a background that shows his commitment to children and science. He taught neuroscience to high school seniors from at-risk schools in Cleveland, Columbus and Chicago through the Kenyon College Academic Partnership and tutored first and second grade at-risk students. He completed a two-year post-baccalaureate research program at the National Institute of Mental Health where he gained vast experience in autism. During this time, he pioneered pharmacological studies testing the therapeutic efficacy of treatments for the social and repetitive behavioral deficits of autism and developed protocols for novel touchscreen technology. Mike’s interests include creating stained glass, sustainable vegetable gardening, snowboarding and pole vaulting. He enjoys spending his free time with his wife and son.

Medical School

2016, MD, University of Kentucky, Lexington, KY


  • 2018, Child Neurology, University of Kentucky, Lexington, KY

  • 2016 to present,  Pediatrics, University of Kentucky, Lexington, KY

Medical Licensure

Kentucky Medical License


  • Advanced Cardiovascular Life Support (ACLS)

  • Neonatal Resuscitation Program

  • Pediatric Advanced Life Support (PALS)

Hospital Privileges

  • University of Kentucky Chandler Medical Center

Professional Memberships

  • American Academy of Neurology (AAN)


  • CASPER Psychology Volunteer Award, 2013—2014

  • Introduction to Clinical Medicine (ICM) Award, 2012—2013

Publications and Abstracts

  • Silverman JL, Gastrell PT, Karras MN, Solomon M, Crawley JN. Cognitive abilities on transitive inference using a novel touchscreen technology for mice. Cerebral cortex (New York, N.Y. : 1991). 2015; 25 (5) : 1133-42.

  • Silverman JL, Babineau BA, Oliver CF, Karras MN, Crawley JN. Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism. Neuropharmacology. 2013; 68 : 210-22.

  • Silverman JL, Oliver CF, Karras MN, Gastrell PT, Crawley JN. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology. 2013; 64 : 268-82.

  • Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, Bryce DK, Smith DL, Fonseca K, Ring RH, Crawley JN. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Science translational medicine. 2012; 25: 4 (131) : 131ra51.